| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,650 |
3,440 |
$370K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,581 |
23,599 |
$144K |
| D0191 |
|
11,482 |
11,211 |
$133K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,275 |
6,665 |
$101K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,122 |
5,973 |
$35K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,147 |
5,013 |
$28K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,452 |
5,143 |
$20K |
| D1206 |
Topical application of fluoride varnish |
1,084 |
1,062 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,955 |
1,848 |
$10K |
| 90670 |
|
1,916 |
1,864 |
$5K |
| 90686 |
|
2,163 |
2,130 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
740 |
722 |
$5K |
| 90723 |
|
897 |
882 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
61 |
30 |
$4K |
| 90647 |
|
860 |
844 |
$3K |
| 90680 |
|
805 |
780 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
144 |
143 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
149 |
125 |
$2K |
| 90633 |
|
221 |
218 |
$731.12 |
| 83655 |
|
385 |
367 |
$274.68 |
| 99383 |
|
24 |
24 |
$202.51 |
| 92551 |
|
8,298 |
7,976 |
$68.06 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,124 |
2,030 |
$67.68 |
| 90677 |
|
248 |
241 |
$65.88 |
| 96160 |
|
2,097 |
2,002 |
$60.43 |
| 85018 |
|
553 |
533 |
$55.13 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,605 |
3,508 |
$27.32 |
| 96127 |
|
146 |
134 |
$20.10 |
| 96161 |
|
3,291 |
3,159 |
$16.68 |
| 99173 |
|
3,434 |
3,298 |
$5.48 |
| 94760 |
|
5,014 |
4,752 |
$0.00 |
| 36416 |
|
1,945 |
1,796 |
$0.00 |
| 90698 |
|
344 |
326 |
$0.00 |
| 90656 |
|
90 |
88 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
161 |
161 |
$0.00 |
| 90651 |
|
70 |
69 |
$0.00 |
| 90744 |
|
167 |
147 |
$0.00 |
| 3008F |
|
12 |
12 |
$0.00 |
| 99177 |
|
2,191 |
2,160 |
$0.00 |
| 90685 |
|
256 |
204 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
63 |
63 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
259 |
246 |
$0.00 |
| 90672 |
|
13 |
13 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
29 |
27 |
$0.00 |